Roche did their first live in-booth unveiling of the cobas Mass Spec solution on Tuesday, July 28 at the Association for Diagnostics & Laboratory Medicine (ADLM) Annual Scientific Meeting & Clinical Lab Expo. cobas Mass Spec and a number of other products are still on display at booth #2901.
The cobas Mass Spec solution, which includes the cobas i 601 analyzer and Ionify reagents with CLIA “moderate complexity” classification, is designed to bring highly complex testing out of specialized units and into routine clinical core laboratories. From sample preparation to final result interpretation, this solution integrates end-to-end processing and eliminates labor-intensive manual workflows, helping laboratory professionals focus on higher-value work.
Roche’s offerings are designed to expand access to high-precision testing, automate laboratory workflows and improve operational efficiency as clinical laboratories face ongoing staffing shortages and increasingly complex workflows.
Visitors can explore interactive demonstrations focused on neurology, oncology and cardiometabolic health, highlighting innovations across core, molecular and pathology labs and point-of-care settings.
Additionally, booth #2901 is featuring:
- The new AXELIOS 1 next-generation sequencing platform
- cobas connection modules (CCM) Vertical
- cobas mobile solution
- cobas pure integrated solution
- cobas pro integrated solutions
- cobas 6800/8800 system (Version 2.0)
- cobas 5800 system
- cobas prime pre-analytical system
- cobas eplex system
- VENTANA DP 600 slide scanner
- BenchMark ULTRA PLUS system
- cobas liat system
- cobas pulse system
- cobas Urisys 1100
- CoaguChek XS Plus system
- The Elecsys Phospho-Tau (181P) blood-based biomarker test
- navify Digital Solutions
Visit Roche for more information
